Home / Share Price Target / Metropolis
Metropolis Healthcare Share Price Target 2024, 2025, 2026 to 2039 With Charts
Metropolis Healthcare Limited | |||
Symbol: METROPOLIS | |||
Price: ₹2,045 | |||
Exchange: NSE | |||
Healthcare -> Diagnostics & Research |
Show Table of Contents
Table of Contents
- 1: Metropolis Healthcare Brief Company Overview
- 1.1: Metropolis Healthcare Limited: A Trusted Diagnostic Provider
- 1.2: Metropolis Healthcare Financial Performance
- 1.2.1: Is Metropolis Healthcare A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Metropolis Healthcare Share Price Target For 2024
- 2.1.1: Metropolis Healthcare Share Price Target Table For 2024
- 2.1.2: Summary: Metropolis Healthcare Share Price Prediction For 2024
- 2.2: Metropolis Healthcare Share Price Target For 2025
- 2.2.1: Metropolis Healthcare Share Price Target Table For 2025
- 2.2.2: Summary: Metropolis Healthcare Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Metropolis Healthcare Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Metropolis Healthcare Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Metropolis Healthcare Past Performance
Metropolis Healthcare Brief Company Overview
Metropolis Healthcare Limited: A Trusted Diagnostic Provider
Metropolis Healthcare Limited is a leading diagnostic services provider in India. Established in 1981, the company has a strong market presence and a reputation for excellence.
Key products and services include:
- Clinical laboratory testing: Oncology, neurology, gynecology, nephrology
- Health check-up packages: Men, women, senior citizens, youth, corporates
- Corporate wellness and hospital laboratory solutions
- Clinical research services
Metropolis Healthcare is committed to providing accurate, reliable, and timely diagnostic services. With its diverse product range and commitment to excellence, the company is well-positioned to meet the growing demand for diagnostic services in India.
Advertisement
Metropolis Healthcare Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 10,845.34 Crore | Market valuation of Metropolis Healthcare's shares. |
Revenue (TTM) | 1,243.97 Crore | Total revenue generated by Metropolis Healthcare over the past twelve months. |
Net Income (TTM) | +136.96 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 17% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 11.01% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | +13.1% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) | +31.8% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio | 17.92 | Company's total debt divided by total shareholder equity. |
Total Debt | 197.06 Crore | Sum of Metropolis Healthcare's current & long-term financial obligations. |
Total Cash | 116.04 Crore | Total amount of liquid funds available to Metropolis Healthcare. |
Beta | 0.34 | Beta is less than 1 indicating that the Metropolis Healthcare's price is less volatile than the market. |
Is Metropolis Healthcare A Good Buy For Long Term?
No valid response content found
To predict the Metropolis Healthcare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Metropolis Healthcare Share Price Target For 2024
The line chart displays the monthly closing prices of Metropolis Healthcare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Metropolis Healthcare shares in 2024, see the table below.
Advertisement
Metropolis Healthcare Share Price Target Table For 2024
Metropolis Healthcare's Levels | Value | Reason/Importance |
---|---|---|
2024 Target 3 | 2123.80 (+3.85%) | Price Action: Oct 2024 Low |
2024 Target 2 | 2101.00 (+2.73%) | Price Action: Jul 2024 Low |
2024 Target 1 | 2079.74 (+1.69%) | Custom Fibonacci Extension Lvl 23.6% |
Current Price | 2045.00 | Metropolis Healthcare's 1 share price as of Wed 13 Nov 2024 |
Stop Loss 1 | 2034.33 (-0.53%) | Price Action: Chart |
Stop Loss 2 | 1995.64 (-2.42%) | Fibonacci Retracement Extended 28.2% |
Stop Loss 3 | 1961.45 (-4.09%) | Price Action: Jan 2021 Low |
Summary: Metropolis Healthcare Share Price Prediction For 2024
In summary, Metropolis Healthcare has surged by ₹366.85, achieving a notable +21.86% increase from 1st January 2024 to 13 Nov 2024. Our analysis of Metropolis Healthcare for 2024 predicts an additional rise of 1.69% to 3.85% by the end of 2024 with three potential targets T1: 2079.74, T2: 2101.00, T3: 2123.80. Stop Loss at SL1: 2034.33, SL2: 1995.64, SL3: 1961.45.
Metropolis Healthcare has a 52-week high of ₹2318.30, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1450.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Metropolis Healthcare.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Metropolis Healthcare Share Price Target For 2025
The line chart displays the monthly closing prices of Metropolis Healthcare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Metropolis Healthcare shares in 2025, see the table below.
Advertisement
Metropolis Healthcare Share Price Target Table For 2025
Metropolis Healthcare's Levels | Value | Reason/Importance |
---|---|---|
2025 Target 3 | 2661.12 (+30.12%) | Price Action: Chart |
2025 Target 2 | 2611.50 (+27.7%) | Fibonacci Extension Level 150% |
2025 Target 1 | 2568.74 (+25.61%) | Custom Fibonacci Extension Lvl 64.9% |
Current Price | 2045.00 | Metropolis Healthcare's 1 share price as of Wed 13 Nov 2024 |
Stop Loss 1 | 1918.00 (-6.22%) | Price Action: Aug 2020 High |
Stop Loss 2 | 1887.78 (-7.69%) | Technical Indicator: MA250 |
Stop Loss 3 | 1849.90 (-9.55%) | Price Action: Apr 2024 High |
Summary: Metropolis Healthcare Share Price Prediction For 2025
In summary, Metropolis Healthcare has surged by ₹366.85, achieving a notable +21.86% increase from 1st January 2024 to 13 Nov 2024. Our analysis of Metropolis Healthcare for 2025 predicts an additional rise of 25.61% to 30.12% by the end of 2025 with three potential targets T1: 2568.74, T2: 2611.50, T3: 2661.12. Stop Loss at SL1: 1918.00, SL2: 1887.78, SL3: 1849.90.
Metropolis Healthcare has a All-Time high of ₹3579.89, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1450.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Metropolis Healthcare, we have created a specific page for that check here: Metropolis Healthcare Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Metropolis Healthcare Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Metropolis Healthcare share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 11.7% over the next 15 years.
For complete year by year Metropolis Healthcare long term share price target from 2024, 2025 to 2039 check the below table.
Metropolis Healthcare Share Price Target Table From 2024, 2025, 2026 to 2039
Year | Metropolis Healthcare Target | YoY Change % |
---|---|---|
2024 | ₹2,045 | [Current Price] |
2024 | ₹2,329.06 | 13.89% |
2025 | ₹2,933.57 | 25.95% |
2026 | ₹3,485.34 | 18.8% |
2027 | ₹4,130.6 | 18.51% |
2028 | ₹4,719.78 | 14.26% |
2029 | ₹5,335.69 | 13.04% |
2030 | ₹5,943.47 | 11.39% |
2031 | ₹6,452.49 | 8.56% |
2032 | ₹7,135.47 | 10.58% |
2033 | ₹7,717.14 | 8.15% |
2034 | ₹8,342.32 | 8.1% |
2035 | ₹8,953.36 | 7.32% |
2036 | ₹9,419.64 | 5.2% |
2037 | ₹10,140.33 | 7.65% |
2038 | ₹10,714.51 | 5.66% |
2039 | ₹10,965.47 | 2.34% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Metropolis Healthcare Past Performance
- In 2019, Metropolis Healthcare opening price was ₹956.7
- As of Wed 13 Nov 2024 the price stands at ₹2,045.
- This represents a Compound Annual Growth Rate (CAGR) of 13.5%.
- In 5 years, an investment of 10,000 would have become ₹21,375.56.
As we wrap up, we hope you like our study on Metropolis Healthcare share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Metropolis Healthcare Share Price History
- Metropolis Healthcare Price Target Tomorrow
- Metropolis Healthcare Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.